June 22, 2010 – Riverain Medical announced this week that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now